{
    "download_date": [
        "ClinicalTrials.gov processed this data on May 09, 2023"
    ],
    "link_text": [
        "Link to the current ClinicalTrials.gov record."
    ],
    "url": [
        "https://clinicaltrials.gov/show/NCT05482828"
    ],
    "org_study_id": [
        "B100013"
    ],
    "nct_id": [
        "NCT05482828"
    ],
    "brief_title": [
        "Effect of Jaeumgeonbi-Tang on Chronic Subjective Dizziness"
    ],
    "official_title": [
        "Effect of Jaeumgeonbi-Tang on Chronic Subjective Dizziness: A Randomized, Double-Blind, Parallel-group, Placebo-Controlled Trial"
    ],
    "lead_sponsor": [],
    "source": [
        "Korea Health Industry Development Institute"
    ],
    "has_dmc": [
        "Yes"
    ],
    "textblock": [
        "The goal of this study is to assess the safety and efficacy of JGT (Jaeumgeonbi-Tang). A\r\n      randomized, double-blind, parallel-group, placebo-controlled clinical trial was conducted and\r\n      changes in symptoms and quality of life of the patients were evaluated.",
        "This study's protocol was designed to assess the efficacy of JGT (Jaeumgeonbi-Tang) for\r\n      chronic subjective dizziness.\r\n\r\n        -  This design of the study is a randomized, double-blind, parallel-group,\r\n           placebo-controlled design.\r\n\r\n        -  Symptoms and quality of life of chronic subjective dizziness patients will be evaluated.\r\n\r\n        -  Dizziness severity and quality of life of the patients will be evaluated using DHI\r\n           (Dizziness Handicap Inventory) (1) before treatment (baseline), (2) after 2 weeks, and\r\n           (3) after 4 weeks of JGT treatment.\r\n\r\n        -  Blood samples of the patients will be gathered before and after JGT treatment for\r\n           pathophysiological analysis."
    ],
    "overall_status": [
        "Suspended"
    ],
    "why_stopped": [
        "The Sponser doesn't fund any more"
    ],
    "start_date": [
        "May 2010"
    ],
    "type": [
        "Actual",
        "Actual",
        "Actual",
        "Actual"
    ],
    "primary_completion_date": [
        "December 2011"
    ],
    "phase": [
        "Phase 2"
    ],
    "study_type": [
        "Interventional"
    ],
    "has_expanded_access": [
        "No"
    ],
    "allocation": [
        "Randomized"
    ],
    "intervention_model": [
        "Parallel Assignment"
    ],
    "primary_purpose": [
        "Treatment"
    ],
    "masking": [
        "Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)"
    ],
    "measure": [
        "Dizziness handicap Inventory"
    ],
    "time_frame": [
        "Change from Baseline DHI score at 4 weeks"
    ],
    "description": [
        "The DHI (Dizziness Handicap Inventory) is a 25-item self-report questionnaire that quantifies the effect of dizziness on daily life by measuring the self-perceived handicap of the patients.",
        "Treatment group: JGT (Jaeumgeonbi-Tang) tablet. 8 g t.i.d. for 28 days",
        "Placebo group: Corn starch tablet, 8 g t.i.d. for 28 days",
        "JGT tablet (composed of 19 herbs), 24 g daily (single dose=8 g), t.i.d. for 28 days",
        "Corn starch tablet, 24 g daily (single dose=8 g), t.i.d. for 28 days"
    ],
    "number_of_arms": [
        2.0
    ],
    "enrollment": [
        50.0
    ],
    "condition": [
        "Chronic Subjective Dizziness"
    ],
    "arm_group_label": [
        "JGT group",
        "Placebo group",
        "JGT group",
        "Placebo group"
    ],
    "arm_group_type": [
        "Experimental",
        "Placebo Comparator"
    ],
    "intervention_type": [
        "Drug",
        "Drug"
    ],
    "intervention_name": [
        "JGT (Jaeumgeonbi-Tang) tablet",
        "Placebo tablet"
    ],
    "other_name": [
        "JGT (Jaeumgeonbi-Tang) tablet, Hanpoong Co. Ltd",
        "Corn starch tablet"
    ],
    "criteria": [],
    "gender": [
        "All"
    ],
    "minimum_age": [
        "20 Years"
    ],
    "maximum_age": [
        "65 Years"
    ],
    "healthy_volunteers": [
        "No"
    ],
    "last_name": [
        "Yoo HoRyong, KMD, PhD"
    ],
    "role": [
        "Study Director"
    ],
    "affiliation": [
        "Daejeon University"
    ],
    "facility": [],
    "country": [
        "Korea, Republic of"
    ],
    "verification_date": [
        "July 2022"
    ],
    "study_first_submitted": [
        "April 22, 2013"
    ],
    "study_first_submitted_qc": [
        "July 28, 2022"
    ],
    "study_first_posted": [
        "August 1, 2022"
    ],
    "last_update_submitted": [
        "July 28, 2022"
    ],
    "last_update_submitted_qc": [
        "July 28, 2022"
    ],
    "last_update_posted": [
        "August 1, 2022"
    ],
    "responsible_party_type": [
        "Principal Investigator"
    ],
    "investigator_affiliation": [
        "Korea Health Industry Development Institute"
    ],
    "investigator_full_name": [
        "Ho Ryong Yoo"
    ],
    "investigator_title": [
        "Associate Professor, Daejeon University"
    ],
    "keyword": [
        "Chronic subjective dizziness",
        "Oxidative stress"
    ],
    "mesh_term": [
        "Dizziness"
    ],
    "sharing_ipd": [
        "No"
    ]
}